My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
MRPL declines after posting disappointing Q1 numbers
Jul 24,2017

The result was announced after market hours on Friday, 21 July 2017.

Meanwhile, the S&P BSE Sensex was up 174.67 points, or 0.55% at 32,203.56.

High volumes were witnessed on the counter. On the BSE, 3.88 lakh shares were traded on the counter so far as against the average daily volumes of 2.87 lakh shares in the past one quarter. The stock had hit a high of Rs 123.80 and a low of Rs 117.90 so far during the day. The stock had hit a 52-week high of Rs 142.75 on 18 May 2017 and a 52-week low of Rs 74.40 on 12 August 2017.

The stock had underperformed the market over the past one month till 21 July 2017, gaining 1.98% compared with 2.38% rise in the Sensex. The scrip had also underperformed the market in past one quarter, rising 2.26% as against Sensexs 9.07% rise. The scrip had, however, outperformed the market in past one year, gaining 58.32% as against Sensexs 15.58% rise.

The large-cap company has equity capital of Rs 1,752.60 crore. Face value per share is Rs 10.

Mangalore Refinery and Petrochemicals (MRPL) increase in revenue was mainly on account of increase in the product prices in Q1 June 2017. The percentage of dispatches for export sales to total sales has decreased due to more domestic off take.

The decrease in profit was on account of reduction in prices of crude oil and finished products, which has resulted in inventory loss of Rs 438 crore in Q1 June 2017, compared to inventory gain of Rs 859 crore in Q1 June 2016.

The gross refining margin (GRM) has fallen to $4.74 per barrel in Q1 June 2017 from GRM of $10.01 per barrel in Q1 June 2016.

Mangalore Refinery and Petrochemicals is a subsidiary of ONGC with ONGC holding 71.63% stake in the firm (as per the shareholding pattern as on 30 June 2017). The company operates in the petroleum sector.

Powered by Capital Market - Live News

Divis Labs drops on dismal Q1 results
Jul 24,2017

The result was announced on Saturday, 22 July 2017.

Meanwhile, the S&P BSE Sensex was up 144.53 points, or 0.47% to 32,179.92.

On the BSE, 1.05 lakh shares were traded in the counter so far, compared with average daily volumes of 2.49 lakh shares in the past one quarter. The stock had hit a high of Rs 699.75 and a low of Rs 680.35 so far during the day. The stock had hit a record high of Rs 1,380 on 16 September 2016. The stock had hit a 52-week low of Rs 533.10 on 29 May 2017.

The stock has dropped 8.62% in three sessions to its current price, from a close of Rs 754.80 on 19 July 2017.

The stock had outperformed the market over the past one month till 21 July 2017, gaining 11.88% compared with 2.38% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 14.21% as against Sensexs 9.07% rise. The scrip had, however, underperformed the market in past one year, falling 39.05% as against Sensexs 15.58% rise.

The large-cap company has equity capital of Rs 53.09 crore. Face value per share is Rs 2.

Divis Laboratories revenue in Q1 has been impacted due to the time required for setting up protocols and procedures for release of export shipments as stipulated in the import alert by the US drug regulator. This has since been established and shipments for the exempted products are being done as per the protocols.

Divis Laboratories is primarily engaged in the manufacture of active pharmaceutical ingredients (APIs) & intermediates for generics; custom synthesis of APIs and advanced intermediates for discovery compounds for pharma giants; building blocks for peptides; building blocks for nucleotides; carotenoids; and chiral ligands.

Powered by Capital Market - Live News

Four stocks drop ex-dividend
Jul 24,2017

Meanwhile, the S&P BSE Sensex was up 138.05 points or 0.43% at 32,166.94.

Century Enka fell 1.65% to Rs 396.15 as the stock turned ex-dividend today, 24 July 2017, for dividend of Rs 7 per share for the year ended 31 March 2017. Before turning ex-dividend, the stock offered a dividend yield of 1.74% based on the closing price of Rs 402.80 on BSE on Friday, 21 July 2017.

EIH lost 1.14% to Rs 138.15 as the stock turned ex-dividend today, 24 July 2017, for dividend of Rs 0.90 per share for the year ended 31 March 2017. Before turning ex-dividend, the stock offered a dividend yield of 0.64% based on the closing price of Rs 139.75 on BSE on Friday, 21 July 2017.

Sanghvi Movers fell 0.74% to Rs 243 as the stock turned ex-dividend today, 24 July 2017, for dividend of Rs 4 per share for the year ended 31 March 2017. Before turning ex-dividend, the stock offered a dividend yield of 1.63% based on the closing price of Rs 244.80 on BSE on Friday, 21 July 2017.

Kalyani Steels lost 0.71% to Rs 445.75 as the stock turned ex-dividend today, 24 July 2017, for dividend of Rs 5 per share for the year ended 31 March 2017. Before turning ex-dividend, the stock offered a dividend yield of 1.11% based on the closing price of Rs 448.95 on BSE on Friday, 21 July 2017.

Powered by Capital Market - Live News

Avenue Supermarts attracts shoppers after strong Q1 outcome
Jul 24,2017

The result was announced on Saturday, 22 July 2017.

Meanwhile, the S&P BSE Sensex was up 85.52 points or 0.27% at 32,114.41

On the BSE, 1.17 lakh shares were traded in the counter so far, compared with average daily volumes of 2.31 lakh shares in the past one quarter. The stock hit a high of Rs 964.25 in intraday trade so far, which is a record high for the counter. The stock had hit a low of Rs 930.25 so far during the day. The stock hit a record low of Rs 558.75 on 21 March 2017.

The large-cap company has equity capital of Rs 624.08 crore. Face value per share is Rs 10.

Avenue Supermarts companys earnings before interest, taxation, depreciation and amortization (EBITDA) rose 29.2% to Rs 303 crore in Q1 June 2017 over Q1 June 2016. EBITDA margin fell to 8.4% in Q1 June 2017 from 8.8% in Q1 June 2016.

Avenue Supermarts said that the company follows everyday low cost - everyday low price (EDLC-EDLP) strategy which aims at procuring goods at competitive price, using operational and distribution efficiency and thereby delivering value for money to customers by selling at competitive prices.

Shares of Avenue Supermarts had debuted at Rs 604.40 on BSE, a premium of 102.14% to the initial public offer (IPO) price of Rs 299 per share on 21 March 2017. The stock had settled at Rs 640.75 on that day, a premium of 114.29% over its IPO price.

The IPO of Avenue Supermarts closed with strong response from investors. The IPO received bids for 464.08 crore shares compared with 4.43 crore shares on offer. The IPO was subscribed 104.59 times. The issue opened for bidding on 8 March 2017 and closed on 10 March 2017.

Avenue Supermarts is a Mumbai-based company, which owns and operates D-Mart stores. D-Mart is an emerging national supermarket chain that offers customers a range of home and personal products under one roof. The company offers a wide range of products with a focus on Foods, Non-Foods (FMCG) and General Merchandise & Apparel product categories. As of 30 June 2017, the company had 132 stores with Retail Business Area of 4.1 million sq.ft. across Maharashtra, Gujarat, Andhra Pradesh, Karnataka, Telangana, Tamil Nadu, Madhya Pradesh, Rajasthan, NCR, Chhattisgarh and Punjab.

Powered by Capital Market - Live News

Lupin gains as Goa facility clears US FDA inspection
Jul 24,2017

The announcement was made after market hours on Friday, 21 July 2017.

Meanwhile, the S&P BSE Sensex was up 90.04 points or 0.28% at 32,118.93.

On the BSE, 30,000 shares were traded on the counter so far as against the average daily volumes of 1.54 lakh shares in the past one quarter. The stock had hit a high of Rs 1,174.85 and a low of Rs 1,152.20 so far during the day. The stock had hit a 52-week high of Rs 1,750 on 29 July 2016 and a 52-week low of Rs 1,036.80 on 5 July 2017.

The large-cap company has equity capital of Rs 90.34 crore. Face value per share is Rs 2.

Lupin announced the successful completion of a PAI inspection (Prior Approval Inspection) carried out by the United States Food and Drug Administration (USFDA) at its Goa manufacturing facility without any observations. The inspection which started on Monday, 17 July 2017 was concluded by afternoon Friday, 21 July 2017, Lupin said.

On consolidated basis, Lupins net profit fell 49.16% to Rs 380.21 crore on 1.29% growth in net sales to Rs 4161.88 crore in Q4 March 2017 over Q4 March 2016.

Lupin is a transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.

Powered by Capital Market - Live News

Tinplate surges after stellar Q1 earnings
Jul 21,2017

The result was announced during market hours today, 21 July 2017.

Meanwhile, the S&P BSE Sensex was up 113.75 points or 0.36% at 32,018.15. The S&P BSE Small-Cap index rose 5.66 points or 0.04% at 16,005.54.

On the BSE, 19.96 lakh shares were traded on the counter so far as against the average daily volumes of 3.42 lakh shares in the past one quarter. The stock had hit a high of Rs 149.90 so far during the day, which is a 52-week high. The stock hit a low of Rs 136.70 so far during the day. The stock had hit a 52-week low of Rs 64 on 9 November 2016.

The stock had outperformed the market over the past one month till 20 July 2017, advancing 49.06% compared with the Sensexs 1.94% rise. The stock had also outperformed the market over the past one quarter, gaining 58.91% as against the Sensexs 8.44% rise. The scrip had also outperformed the market over the past one year, advancing 41.22% as against the Sensexs 14.29% rise.

The small-cap company has equity capital of Rs 104.67 crore. Face value per share is Rs 10.

Tinplate Company of India is one of the leading indigenous producers of tin coated and tin free steel sheets in India.

Powered by Capital Market - Live News

Rallis India drops after weak Q1 results
Jul 21,2017

The announcement was made after market hours yesterday, 20 July 2017.

Meanwhile, the S&P BSE Sensex was up 117.04 points or 0.37% at 32,021.44. The S&P BSE Mid-Cap index was up 9.67 points or 0.06% at 15,188.94.

On the BSE, 26,657 shares were traded in the counter so far as against average daily volume of 34,892 shares in the past one quarter. The stock had hit a high of Rs 241.80 and a low of Rs 236 so far during the day. The stock had hit a 52-week high of Rs 264.60 on 31 March 2017. The stock had hit a 52-week low of Rs 180.25 on 22 November 2016.

The stock had underperformed the market over the past one month till 20 July 2017, declining 0.47% compared with Sensexs 1.94% rise. The scrip had also underperformed the market in past one quarter, declining 5.12% as against Sensexs 8.44% rise. The scrip had, however, outperformed the market in past one year, jumping 15.54% as against Sensexs 14.29% rise.

The mid-cap company has equity capital of Rs 19.45 crore. Face value per share is Re 1.

ln the crop protection segment the company has witnessed destocking by dealers ahead of GST implementation and down trading by framers. Consequently placement was muted during Q1 compared to the regular scale, which has since picked up in July 2017.

The board approved the divestment of its entire shares comprising 1.82 crore share or 13.68% in Advinus Therapeutics to Eurofins Pharma Services Lux Holdings SARL for Rs 17.32 crore.

The board also approved the scheme of amalgamation for the merger of Zero Waste Agro-Organics Limited, wholly owned subsidiary of the company, with the company, subject to such approvals as may be required.

Zero Waste Agro-Organics is engaged in the business of manufacture of scientifically enriched organic compost. The scheme will help in achieving cost effectiveness, operational and management efficiency.

Rallis India is one of Indias leading agrochemicals companies.

Powered by Capital Market - Live News

Atul slips after weak Q1 numbers
Jul 21,2017

The result was announced during market hours today, 21 July 2017.

Meanwhile, the S&P BSE Sensex was up 22.70 points, or 0.07% at 31,927.10. The S&P BSE Mid-Cap index was down 15.06 points, or 0.1% at 15,164.21.

On the BSE, 6,450 shares were traded on the counter so far as against the average daily volumes of 8,419 shares in the past one quarter. The stock had hit a high of Rs 2,408.55 and a low of Rs 2,275 so far during the day. The stock had hit a record high of Rs 2,588 on 16 May 2017 and a 52-week low of Rs 1,885 on 10 August 2016.

The stock had underperformed the market over the past one month till 20 July 2017, declining 3.41% compared with the Sensexs 1.94% rise. The scrip had also underperformed the market over the past one quarter sliding 1.52% as against the Sensexs 8.44% rise. The scrip had also underperformed the market over the past one year advancing 11.14% as against the Sensexs 14.29% rise.

The mid-cap company has equity capital of Rs 29.66 crore. Face value per share is Rs 10.

Atul is an integrated chemical company. The company operates through two segments: life science chemicals, and performance and other chemicals.

Powered by Capital Market - Live News

RIL strengthens after board recommends 1:1 bonus issue
Jul 21,2017

The announcement was made during market hours today, 21 July 2017.

Meanwhile, the S&P BSE Sensex was up 14.40 points or 0.05% at 31,918.80.

High volumes were witnessed on the counter. On the BSE, 15.41 lakh shares were traded on the counter so far as against the average daily volumes of 3.94 lakh shares in the past one quarter. The stock had hit a high of Rs 1,588.20 in intraday trade, which is also a 52-week high for the stock. The stock had hit a low of Rs 1,544.40 so far during the day. The stock had hit a 52-week low of Rs 932 on 9 November 2016.

The stock had outperformed the market over the past one month till 20 July 2017, gaining 8.25% compared with Sensexs 1.94% rise. The scrip had also outperformed the market in past one quarter, rising 11.63% as against Sensexs 8.44% rise. The scrip had also outperformed the market in past one year, jumping 49.5% as against Sensexs 14.29% rise.

The large-cap company has equity capital of Rs 3251.74 crore. Face value per share is Rs 10.

Reliance Industries (RIL) consolidated net profit rose 28% to Rs 9108 crore on 26.7% rise in revenue to Rs 90537 crore in Q1 June 2017 over Q1 June 2016. The announcement was made after market hours yesterday, 20 July 2017.

Reliance Industries (RIL) increase in revenue is primarily on account of increase in prices and volumes of refining and petrochemical products partially offset by lower prices and volumes from exploration and production (E&P) business. Revenue was also boosted by robust growth in retail business which recorded a 73.6% increase in revenue to Rs 11571 crore. Reliance Retail witnessed growth across all consumption baskets during the quarter.

Strong refining and petrochemicals margin environment contributed to higher operating profits for the quarter. Gross refining margins recorded nine-year-high of $ 11.9 per bbl whereas petrochemicals EBIT (earnings before interest and depreciation) margin were at all-time high of 15.8%. Gross refining margin rose to $11.9 per barrel in Q1 June 2017 from $11.5 per barrel in Q1 June 2016.

Meanwhile, the board of directors of RIL considered and approved an investment in Balaji Telefilms (BTL), to acquire 2.52 crore equity shares constituting 24.92% of BTLs equity, through subscription to preferential issue of shares by BTL to RIL for cash consideration of Rs 164 per equity share amounting to an investment of Rs 413.28 crore. This investment in content production (including digital content) is in line with RILs commitment to invest and grow in telecom digital and media businesses.

BTL has launched a new digital platform, ALTBalaji (ALT), in April 2017, which has garnered over 3 million downloads and subscribers from over 75 countries since its launch. The transaction is subject to BTLs shareholder approval and regulatory compliances and other conditions precedent and is expected to be completed in 45 to 60 days.

Shares of Balaji Telefilms gained 1.02% to Rs 188.55.

The RILs board has also approved to set up and invest in a technology incubator by the name Jerusalem Innovation Incubator (JII), licensed by Israel Innovation Authority (IIA), Ministry of Economy, Israel, under competitive bidding process.

The investment in JII shall be done in partnership with OurCrowd, Motorola Solutions and Yissum. JII will be in the form of limited liability partnership with RIL holding 20% interest. OurCrowd will hold 60%, Motorola 20% and Yissum.

RIL proposes to invest upto $25 million in JII and in frontier technology start-ups in tranches, over a period of about 8 years.

RIL is Indias largest private sector company. RILs activities span hydrocarbon exploration and production, petroleum refining and marketing, petrochemicals, retail and telecommunications.

Powered by Capital Market - Live News

Ashok Leyland declines after poor Q1 earnings
Jul 21,2017

The result was announced during market hours today, 21 July 2017.

Meanwhile, the S&P BSE Sensex was up 5.95 points or 0.02% at 31,910.35.

On the BSE, 22.49 lakh shares were traded on the counter so far as against the average daily volumes of 16.82 lakh shares in the past one quarter. The stock had hit a high of Rs 106.15 and a low of Rs 100 so far during the day. The stock had hit a 52-week high of Rs 109.50 on 18 July 2017 and a 52-week low of Rs 73.60 on 22 November 2016.

The stock had outperformed the market over the past one month till 20 July 2017, advancing 13.8% compared with the Sensexs 1.94% rise. The stock had also outperformed the market over the past one quarter, gaining 29.37% as against the Sensexs 8.44% rise. The scrip had, however, underperformed the market over the past one year, advancing 13.38% as against the Sensexs 14.29% rise.

The large-cap company has equity capital of Rs 292.65 crore. Face value per share is Rs 1.

Ashok Leylands profitability in Q1 June 2017 was lower, primarily because of a richer mix and exchange gain on swap contracts in Q1 June 2016. The mix is expected to significantly improve in the coming quarters, the company said. The next 3 quarters look promising as the demand is expected to pick up on the back of Government spending on infrastructure as well as positive impact of GST, it added.

Ashok Leyland is one of the leading manufacturers of medium and heavy commercial vehicles in India.

Powered by Capital Market - Live News

Dish TV India leads losers in A group
Jul 21,2017

Dish TV India slumped 6.1% to Rs 77.8 at 13:45 IST on profit booking after the stock gained 6.08% in three sessions to Rs 82.85 yesterday, 21 July 2017, from a close of Rs 78.10 on 17 July 2017. The stock topped the losers in the BSEs A group. On the BSE, 13.79 lakh shares were traded on the counter so far as against the average daily volumes of 3.34 lakh shares in the past two weeks.

Idea Cellular skidded 5.9% at Rs 89.25. The stock was the second biggest loser in A group. On the BSE, 34.66 lakh shares were traded on the counter so far as against the average daily volumes of 29.57 lakh shares in the past two weeks.

Ashok Leyland dropped 4.58% to Rs 101.10. The stock was the third biggest loser in A group. On the BSE, 20.58 lakh shares were traded on the counter so far as against the average daily volumes of 15.96 lakh shares in the past two weeks.

Dewan Housing Finance Corporation declined 4.27% at Rs 456.20. The stock was the fourth biggest loser in A group. On the BSE, 5.3 lakh shares were traded on the counter so far as against the average daily volumes of 2.09 lakh shares in the past two weeks.

DLF fell 4.01% to Rs 194.85. The stock was the fifth biggest loser in A group. On the BSE, 8.67 lakh shares were traded on the counter so far as against the average daily volumes of 7.54 lakh shares in the past two weeks.

Powered by Capital Market - Live News

Volumes jump at Vesuvius India counter
Jul 21,2017

Vesuvius India clocked volume of 3.96 lakh shares by 13:44 IST on BSE, a 296.58-times surge over two-week average daily volume of 1,000 shares. The stock surged 7.12% at Rs 1,474.90.

Godrej Consumer Products notched up volume of 16.07 lakh shares, a 88.53-fold surge over two-week average daily volume of 18,000 shares. The stock advanced 1% at Rs 965.90.

3M India saw volume of 10,000 shares, a 51.24-fold surge over two-week average daily volume of 197 shares. The stock lost 0.27% at Rs 13,350.

HDFC clocked volume of 37.55 lakh shares, a 29.01-fold surge over two-week average daily volume of 1.29 lakh shares. The stock fell 0.76% at Rs 1,638.50.

Crompton Greaves Consumer Electricals saw volume of 7.62 lakh shares, a 12.65-fold rise over two-week average daily volume of 60,000 shares. The stock rose 1.31% at Rs 209.

Powered by Capital Market - Live News

Indian Bank turns volatile after announcing Q1 numbers
Jul 21,2017

Meanwhile, the S&P BSE Sensex was up 64.12 points or 0.2% at 31,968.52.

On the BSE, 2.53 lakh shares were traded on the counter so far as against the average daily volumes of 1.89 lakh shares in the past one quarter. The stock was volatile. The stock lost as much as 1.27% at the days low of Rs 326.25 so far during the day. The stock rose as much as 2.66% at the days high of Rs 339.25 so far during the day. The stock had hit a record high of Rs 364.80 on 16 May 2017 and a 52-week low of Rs 143.85 on 25 July 2016.

The stock had outperformed the market over the past one month till 20 July 2017, advancing 9.53% compared with the Sensexs 1.94% rise. The stock had also outperformed the market over the past one quarter, gaining 28.36% as against the Sensexs 8.44% rise. The scrip had also outperformed the market over the past one year, surging 113.88% as against the Sensexs 14.29% rise.

The large-cap state-run bank has equity capital of Rs 480.29 crore. Face value per share is Rs 10.

Indian Banks net profit rose 21.16% to Rs 372.40 crore on 3.79% growth in total income to Rs 4788.04 crore in Q1 June 2017 over Q1 June 2016. The result was announced during market hours today, 21 July 2017.

The banks gross non-performing assets (NPAs) stood at Rs 9653.01 crore as on 30 June 2017 as against Rs 9865.13 crore as on 31 March 2017 and Rs 8894.23 crore as on 30 June 2016.

The ratio of gross NPAs to gross advances stood at 7.21% as on 30 June 2017 as against 7.47% as on 31 March 2017 and 6.97% as on 30 June 2016. The ratio of net NPAs to net advances stood at 4.05% as on 30 June 2017 as against 4.39% as on 31 March 2017 and 4.48% as on 30 June 2016.

The banks provisions and contingencies surged 71.59% to Rs 715.55 crore in Q1 June 2017 over Q1 June 2016.

Government of India held 82.11% stake in Indian Bank (as on 30 June 2017).

Powered by Capital Market - Live News

Dr Reddys in pink of health after USFDA clears Mexican facility
Jul 21,2017

The announcement was made during market hours today, 21 July 2017.

Meanwhile, the S&P BSE Sensex was up 49.74 points or 0.16% at 31,954.14.

On the BSE, 11,944 shares were traded on the counter so far as against the average daily volumes of 33,833 shares in the past one quarter. The stock had hit a high of Rs 2,777 and a low of Rs 2,727 so far during the day. The stock had hit a 52-week high of Rs 3,689 on 20 July 2016 and a 52-week low of Rs 2,382.05 on 29 May 2017.

The stock had outperformed the market over the past one month till 20 July 2017, gaining 2.84% compared with Sensexs 1.94% rise. The scrip had, however, underperformed the market in past one quarter, gaining 5.13% as against Sensexs 8.44% rise. The scrip had also underperformed the market in past one year, declining 25.36% as against Sensexs 14.29% rise.

The large-cap company has equity capital of Rs 82.91 crore. Face value per share is Rs 5.

The company will announce Q1 results on 27 July 2017. Dr Reddys Laboratories consolidated net profit rose 175.4% to Rs 337.60 crore on 5.4% decline in net sales to Rs 3554.20 crore in Q4 March 2017 over Q4 March 2016.

Dr Reddys Laboratories is an integrated global pharmaceutical company.

Powered by Capital Market - Live News

Lyka Labs surges 21.44% in seven sessions
Jul 21,2017

Meanwhile, the S&P BSE Sensex was up 59.58 points, or 0.19% at 31,963.98. The S&P BSE Small-Cap index was up 23.91 points, or 0.15% at 16,023.79.

On the BSE, 1.56 lakh shares were traded on the counter so far as against the average daily volumes of 30,801 shares in the past one quarter. The stock had hit a high of Rs 58 and a low of Rs 53 so far during the day. The stock had hit a 52-week high of Rs 78 on 21 July 2016 and a 52-week low of Rs 38.65 on 28 June 2017.

The stock had outperformed the market over the past one month till 20 July 2017, advancing 13.96% compared with the Sensexs 1.94% rise. The scrip had, however, underperformed the market over the past one quarter advancing 1.73% as against the Sensexs 8.44% rise. The scrip had also underperformed the market over the past one year declining 30.56% as against the Sensexs 14.29% rise.

The small-cap company has equity capital of Rs 22.04 crore. Face value per share is Rs 10.

Shares of Lyka Labs rose 21.44% in seven trading sessions to its current market price of Rs 56.35, from a close of Rs 46.40 on 12 July 2017.

Lyka Labs reported consolidated net profit of Rs 1.84 crore in Q4 March 2017, compared with net loss of Rs 11.99 crore in Q4 March 2016. Net sales fell 11.6% to Rs 30.60 crore in Q4 March 2017 over Q4 March 2016.

Lyka Labs is engaged in the manufacturing of pharmaceutical formulations and active pharmaceutical ingredients (APIs) across various therapeutic segments.

Powered by Capital Market - Live News